Quarterly report · Q2
9341.TEDINET S100S8BS
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥6.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥970m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥696m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥971m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.7bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥700m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥971m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥702m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥626m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥438m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥629m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥439m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥6.3bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥5.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥3.1bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.4bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.8bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥4.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.9bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥577m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥434m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥126m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥113m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥71m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥107m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥109m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥35.37 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.01 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥76.61 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.08 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.3 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥35.08 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥73.07 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 74.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥274m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥274m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥73m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥727m |
| jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.7bn |
| jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.7bn |
| jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥983m |
| jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥983m |
| jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥153m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥3.7bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥3.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥267m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥267m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥83m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥557m |
| jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥985m |
| jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥841m |
| jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥841m |
| jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥184m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥1.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 464
| Item | Context | Value | Unit |
|---|---|---|---|
| Deferred tax assets | CurrentQuarterInstant | 67768000 | JPY |
| Other ioa | Prior1YearInstant | 213810000 | JPY |
| Other ioa | CurrentQuarterInstant | 303263000 | JPY |
| Investments and other assets | Prior1YearInstant | 282299000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 371031000 | JPY |
| Noncurrent assets | Prior1YearInstant | 440063000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 534275000 | JPY |
| Assets | Prior1YearInstant | 5414923000 | JPY |
| Assets | CurrentQuarterInstant | 6279885000 | JPY |
| Accounts payable trade | Prior1YearInstant | 159551000 | JPY |
| Accounts payable trade | CurrentQuarterInstant | 124037000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 19128000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 65279000 | JPY |
| Contract liabilities | Prior1YearInstant | 249119000 | JPY |
| Contract liabilities | CurrentQuarterInstant | 248365000 | JPY |
| Income taxes payable | Prior1YearInstant | 307129000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 369359000 | JPY |
| Provision for bonuses | Prior1YearInstant | 45000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 20000000 | JPY |
| Other cl | Prior1YearInstant | 554777000 | JPY |
| Other cl | CurrentQuarterInstant | 569510000 | JPY |
| Current liabilities | Prior1YearInstant | 1334706000 | JPY |
| Current liabilities | CurrentQuarterInstant | 1396552000 | JPY |
| Long term loans payable | Prior1YearInstant | 6941000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 45837000 | JPY |
| Other ncl | Prior1YearInstant | 26401000 | JPY |
| Other ncl | CurrentQuarterInstant | 22514000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 33342000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 68351000 | JPY |
| Liabilities | Prior1YearInstant | 1368049000 | JPY |
| Liabilities | CurrentQuarterInstant | 1464903000 | JPY |
| Capital stock | Prior1YearInstant | 760991000 | JPY |
| Capital stock | CurrentQuarterInstant | 771116000 | JPY |
| Capital surplus | Prior1YearInstant | 660991000 | JPY |
| Capital surplus | CurrentQuarterInstant | 671116000 | JPY |
| Retained earnings | Prior1YearInstant | 2614710000 | JPY |
| Retained earnings | CurrentQuarterInstant | 3240721000 | JPY |
| Treasury stock | Prior1YearInstant | - | JPY |
| Treasury stock | CurrentQuarterInstant | -81000 | JPY |
| Shareholders equity | Prior1YearInstant | 4036693000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 4682873000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 1687000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 2203000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 1687000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 2203000 | JPY |
| Subscription rights to shares | Prior1YearInstant | - | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 118570000 | JPY |
| Non controlling interests | Prior1YearInstant | 8492000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 11336000 | JPY |
| Net assets | Prior1YearInstant | 4046873000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |